Skip to main content

Articles

Cardiometabolic Health

Control of 4 Risk Factors Would Slash CHD Rate in Diabetes by Half

GLP-1 Agonism Holds Promise for Preventing Macrovascular Disease in Type 2 Diabetes

CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins

Belly Fat Triples CV and All-Cause Mortality, Even with Normal Weight

Lifestyle Interventions for Patients with Type 2 Diabetes and Comorbid Kidney Disease

Weight loss from lifestyle changes does not reduce adverse cardiovascular outcomes in patients with type 2 diabetes

New ADA-EASD Position Statement on Managing Hyperglycemia in Type 2 Diabetes favors Individualized Approach

Mounting Evidence that DPP-4 Inhibitors may Reduce Cardiovascular Risk

Management of Multiple Sclerosis: Building Consensus between Healthcare Providers and Payers

Original Research

National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs

Page 188 of 244
Results 1871 - 1880 of 2434